When genomic and standard test results diverge: Implications for breast cancer patients' preference for chemotherapy

Breast Cancer Research and Treatment

Volumn 117, Issue 1, 2009, Pages 25-29

  Brewer, Noel T ^a   Edwards, Alrick S ^a   O'Neill, Suzanne C ^a   Tzeng, Janice P ^a   Carey, Lisa A ^a   Rimer, Barbara K ^a  

^a The University of North Carolina at Chapel Hill   (United States)

Author keywords

Chemotherapy; Genomics; Oncotype DX ; Patient decision making; Risk recurrence

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER PREVENTION; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC RISK; GENOMIC RISK FOR RECURRENCE TEST; HUMAN; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STANDARD RISK FOR RECURRENCE TEST;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DECISION MAKING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SATISFACTION; RISK FACTORS;

EID: 69049109085     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0175-2     Document Type: Article

References (28)

1. AE Guttmacher FS Collins 2002 Genomic medicine - a primer N Engl J Med 347 1512 1520 10.1056/NEJMra012240
2. EW Clayton 2003 Ethical, legal, and social implications of genomic medicine N Engl J Med 349 562 569 10.1056/NEJMra012577
3. KA Phillips DL Veenstra E Oren JK Lee W Sadee 2001 Potential role of pharmacogenomics in reducing adverse drug reactions - a systematic review JAMA 286 2270 2279 10.1001/jama.286.18.2270
4. SL Zheng J Sun F Wiklund S Smith P Stattin G Li et al. 2008 Cumulative association of five genetic variants with prostate cancer N Engl J Med 358 910 919 10.1056/NEJMoa075819
5. HY Chen SL Yu CH Chen GC Chang CY Chen A Yuan et al. 2007 A five-gene signature and clinical outcome in non-small-cell lung cancer N Engl J Med 356 11 20 10.1056/NEJMoa060096
6. M Buyse S Loi L van't Veer G Viale M Delorenzi AM Glas et al. 2006 Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer J Natl Cancer Inst 98 1183 1192
7. JA Foekens D Atkins Y Zhang FC Sweep N Harbeck A Paradiso et al. 2006 Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer J Clin Oncol 24 11 1665 1171 10.1200/JCO.2005.03.9115
8. S Paik S Shak G Tang C Kim J Baker M Cronin et al. 2004 A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 27 2817 2826 10.1056/NEJMoa041588
9. S Paik G Tang S Shak C Kim J Baker W Kim et al. 2006 Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer J Clin Oncol 24 3726 3734 10.1200/JCO.2005.04.7985
10. Early Breast Cancer Trialists' Cooperative Group 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 1687 1717
11. S Swain 2006 A step in the right direction J Clin Oncol 24 3717 3718 10.1200/JCO.2006.06.7025
12. S Paik 2007 Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen Oncologist 12 6 631 635 10.1634/theoncologist.12-6-631
13. MJ van de Vijver YD He LJ van't Veer H Dai AA Hart DW Voskuil et al. 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 25 1999 2009 10.1056/NEJMoa021967
14. Lo SS, Norton J, Mumby PB, Smerage J, Kash J, Chew HK, Hayes D, Epstein A, Albain KS (2007) Prospective multicenter study of the impact of the 21-gene recurrence score (RS) assay on medical oncologist (MO) and patient (pt) adjuvant breast cancer (BC) treatment selection. J Clin Oncol 2007, ASCO Ann Meet Proc Part I, Vol 25, No. 18S
15. Ben-Baruch N, Hammerman A, Klang S, Liebermann N (2007) A prospective study of the impact of the 21-gene recurrence score assay on treatment decisions in N-, ER + early stage breast cancer patients. J Clin Oncol 2007, ASCO Ann Meet Proc (Post-Meeting Edition), Vol 25, No. 18S
16. SE Lillie NT Brewer SC O'Neill EF Morrill EC Dees LA Carey et al. 2007 Retention and use of breast cancer recurrence risk information from genomic tests: the role of health literacy Cancer Epidemiol Biomarkers Prev 16 2 249 255 10.1158/1055-9965.EPI-06-0525
17. J Struewing C Lerman RG Kase TR Giambarresi MA Tucker 1995 Anticipated uptake and impact of genetic testing in hereditary breast and ovarian-cancer families Cancer Epidemiol Biomarkers Prev 4 169 173
18. BK Rimer S Halabi CS Skinner TS Strigo EB Kaplan GP Samsa 2002 Effects of a mammography decision-making intervention at 12 and 24 months Am J Prev Med 22 247 257 10.1016/S0749-3797(02)00417-8
19. TC Davis R Michielutte EN Askov MV Williams BD Weiss 1998 Practical assessment of adult literacy in health care Health Educ Behav 25 5 613 624 10.1177/109019819802500508
20. IA Olivotto CD Bajdik PM Ravdin CH Speers AJ Coldman BD Norris et al. 2005 Population-based validation of the prognostic model ADJUVANT! for early breast cancer J Clin Oncol 23 12 2716 2725 10.1200/JCO.2005.06.178
21. VM Duric PN Butow L Sharpe et al. 2007 Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer Psycho-Oncology 16 1 48 59 10.1002/pon.1045
22. C Lerman C Hughes RT Croyle et al. 2000 Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing Prev Med 31 75 80 10.1006/pmed.2000.0684
23. D Cioffi 1991 Asymmetry of doubt in medical self-diagnosis: the ambiguity of "uncertain wellness" J Pers Soc Psychol 61 6 969 980 10.1037/0022-3514.61.6.969
24. C Lerman B Rimer B Trock A Balshem PF Engstrom 1990 Factors associated with repeat adherence to breast cancer screening Prev Med 119 279 290 10.1016/0091-7435(90)90028-I
25. C Lerman C Hughes BJ Trock RE Myers D Main A Bonney et al. 1999 Genetic testing in families with hereditary nonpolyposis colon cancer JAMA 281 17 1618 1622 10.1001/jama.281.17.1618
26. SC O'Neill NT Brewer BK Rimer SE Lillie EF Morrill EC Dees et al. 2007 Women's interest in gene expression analysis for breast cancer recurrence risk J Clin Oncol 25 29 4628 4634 10.1200/JCO.2006.09.6255
27. CK Hsee GF Loewenstein S Blount MH Bazerman 1999 Preference reversals between joint and separate evaluation of options: a review and theoretical analysis Psychol Bull 125 576 590 10.1037/0033-2909.125.5.576
28. Lo SS, Norton J, Mumby PB et al (2007) Prospective multicenter study of the impact of the 21-gene recurrence score (RS) assay on medical oncologist (MO) and patient (pt) adjuvant breast cancer (BC) treatment selection. J Clin Oncol 2007, ASCO Ann Meet Proc Part I. 20 June 2007;25(suppl 18):(abstract 577)